A classification of antiarrhythmic actions reassessed after a decade of new drugs.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of clinical pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 6144698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiarrhythmic properties of a neuroleptic butyrophenone, melperone, in acute myocardial infarction. A double-blind trial.

  2009cited by this paper
• Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation.

  2009cited by this paper
• Resting and Rate‐Dependent Depression of Maximum Rate of Depolarisation (Vmax) in Guinea Pig Ventricular Action Potentials by Mexiletine, Disopyramide, and Encainide

  1983cited by this paper
• Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification.

  1983cited by this paper
• Importance of physico‐chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea‐pig ventricle

  1983cited by this paper
• Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide.

  1983cited by this paper
• QT and action potential duration.

  1982cited by this paper
• Electrophysiological effects of sotalol--just another beta blocker?

  1982cited by this paper
• VOLTAGE‐ AND TIME‐DEPENDENT DEPRESSION OF MAXIMUM RATE OF DEPOLARIZATION OF GUINEA‐PIG VENTRICULAR ACTION POTENTIALS BY TWO STEROIDAL ANTIARRHYTHMIC DRUGS, CCI 22277 AND ORG 6001

  1982cited by this paper
• Shortening of the Action Potential and Reduction of Pacemaker Activity by Lidocaine, Quinidine, and Procainamide in Sheep Cardiac Purkinje Fibers

  1982cited by this paper
• DIFFERENTIAL ACTIONS ON RABBIT NODAL, ATRIAL, PURKINJE CELL AND VENTRICULAR POTENTIALS OF MELPERONE, A BRADYCARDIC AGENT DELAYING REPOLARIZATION: EFFECTS OF HYPOXIA

  1982cited by this paper
• EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIA

  1982cited by this paper
• Acute prolongation of myocardial refractoriness by sotalol.

  1982cited by this paper
• Mechanisms of Action of Lidocaine and Quinidine on Action Potential Duration in Rabbit Cardiac Purkinje Fibers: An Effect on Steady State Sodium Currents?

  1982cited by this paper
• The effect of prolonged propranolol administration on myocardial transmural capillary density in young rabbits.

  1981cited by this paper
• Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist.

  1981cited by this paper
• Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

  1981cited by this paper
• Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.

  1981cited by this paper
• Adaptation to prolonged beta-blockade of rabbit atrial, purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation.

  1981cited by this paper
• Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

  1981cited by this paper
• Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation.

  1980cited by this paper
• Encainide: a new and potent antiarrhythmic agent.

  1980cited by this paper
• Comparative pharmacokinetics of new antiarrhythmic drugs.

  1980cited by this paper
• Adaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits.

  1980cited by this paper
• Decoupling of heart muscle cells: Correlation with increased cytoplasmic calcium activity and with changes of nexus ultrastructure

  1980cited by this paper
• The generation of electric currents in cardiac fibers by Na/Ca exchange.

  1979cited by this paper
• Reentrant Ventricular Arrhythmias in the Late Myocardial Infarction Period: 7. Effect of Verapamil and D‐600 and the Role of the “Slow Channel”

  1979cited by this paper
• Inactivation of Ca conductance dependent on entry of Ca ions in molluscan neurons.

  1979cited by this paper
• QT interval prolongation as predictor of sudden death in patients with myocardial infarction.

  1978cited by this paper
• Re-entrant Ventricular Arrhythmias in the Late Myocardial Infarction Period: 5. Mechanism of Action of Diphenylhydantoin

  1978cited by this paper
• Shortening effect of tetrodotoxin on action potentials of the conducting system in the dog heart [proceedings].

  1978cited by this paper
• The effect on atrial and ventricular intracellular potentials, and other pharmacological actions of L9146, a non-halogenated benzo(b)thiophene related to amiodarone.

  1977cited by this paper
• Re‐entrant Ventricular Arrhythmias in the Late Myocardial Infarction Period: 4. Mechanism of Action of Lidocaine

  1977cited by this paper
• Cardiac Purkinje fibres

  1977cited by this paper
• Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.

  1977cited by this paper
• Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.

  1977cited by this paper
• Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction.

  1976cited by this paper
• Is potassium conductance of cardiac Purkinje fibres controlled by (Ca2+)?

  1975cited by this paper
• The long Q-T syndrome.

  1975cited by this paper
• The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits.

  1975cited by this paper
• Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

  1974cited by this paper
• Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.

  1974cited by this paper
• Effects of procaine amide on the electrophysiologic properties of the canine ventricular conducting system.

  1973cited by this paper
• Electrophysiological effects of lidocaine on distal Purkinje fibers of canine heart.

  1973cited by this paper
• Effects of noradrenaline and isoprenaline, in combination with α‐ and β‐receptor blocking substances, on the action potential of cardiac Purkinje fibres

  1973cited by this paper
• Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac Purkinje fibers.

  1972cited by this paper
• The effect of thyroid state on monophasic action potential in human heart

  1972cited by this paper
• A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function.

  1972cited by this paper
• Membrane Currents in Mammalian Ventricular Heart Muscle Fibers Using a Voltage-Clamp Technique

  1971cited by this paper
• Antiarrhythmic drugs: electrophysiological actions.

  1971cited by this paper
• A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor.

  1971cited by this paper
• Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle

  1971cited by this paper
• The effect of altered thyroid state on atrial intracellular potentials

  1970cited by this paper
• Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man

  1970cited by this paper
• The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle

  1970cited by this paper
• A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

  1970cited by this paper
• Effect of lidocaine on conduction in canine Purkinje fibers and at the ventricular muscle-Purkinje fiber junction.

  1970cited by this paper
• Electrophysiologic effects of bretylium tosylate on single fibers of the canine specialized conducting system and ventricle.

  1970cited by this paper
• Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres

  1969cited by this paper
• Electrophysiological Actions of Lidocaine on Canine Ventricular Muscle and Purkinje Fibers

  1969cited by this paper
• The effect of bretylium on intracellular cardiac action potentials in relation to its anti‐arrhythmic and local anaesthetic activity

  1969cited by this paper
• Reconstruction of the repolarization process in cardiac Purkinje fibres based on voltage clamp measurements of membrane current

  1969cited by this paper
• [Research on the benzofuran series. XL. Anti-arrhythmic properties of amiodarone].

  1969cited by this paper
• Myocardial alpha and beta adrenergic receptors as demonstrated by atrial functional refractory-period changes.

  1966cited by this paper
• A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN.

  1964cited by this paper
• ELECTROPHYSIOLOGIC ANTAGONISM AND SYNERGISM OF POTASSIUM AND ANTIARRHYTHMIC AGENTS.

  1963cited by this paper
• Antifibrillatory action

  1962cited by this paper
• A comparison of tests for antifibrillatory action.

  1961cited by this paper
• Single fiber recording of the effects of quinidine at atrial and pacemaker sites in the isolated right atrium of the rabbit.

  1960cited by this paper
• The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records.

  1958cited by this paper
• The differential effect of quinidine and pyrilamine on the myocardial action potential at various rates of stimulation.

  1957cited by this paper
• The effect of the cardiac membrane potential on the rapid availability of the sodium‐carrying system

  1955cited by this paper

• Effect of bone marrow stem cell conditioned medium on amiodarone-induced submandibular salivary gland and kidney damage in male albino rats

  2026cites this paper
• Premature ventricular contraction–induced ventricular dysfunction in children without structural heart disease: a systematic review and meta-analysis

  2025cites this paper
• Brazilian Atrial Fibrillation Guidelines - 2025.

  2025cites this paper
• Water-soluble vidarabine derivatives alleviate catecholamine-induced heart failure and arrhythmia without impairing cardiac function in mice

  2025cites this paper
• Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis

  2025cites this paper
• Treating Cardiovascular Disorders with Personalized Medicine.

  2025cites this paper
• Arrhythmogenic and Side Effects of Antiarrhythmic Medications.

  2025cites this paper
• Differential Inhibition by Cenobamate of Canonical Human Nav1.5 Ion Channels and Several Point Mutants

  2025cites this paper
• Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2025cites this paper
• Physicochemical and microbiological stability of 40 mg/mL amiodarone hydrochloride oral suspension.

  2024cites this paper
• A Comparison of the Impact of Pharmacological Treatments on Cardioversion, Rate Control, and Mortality in Data-Driven Atrial Fibrillation Phenotypes in Critical Care

  2024cites this paper
• External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.

  2024cites this paper
• An overview of drug‐induced sodium channel blockade and changes in cardiac conduction: Implications for drug safety

  2024cites this paper
• Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function

  2023cites this paper
• Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?

  2023cites this paper
• Selective Inhibition of Cardiac Late Na+ Current Is Based on Fast Offset Kinetics of the Inhibitor

  2023cites this paper
• In Vitro Models for Improved Therapeutic Interventions in Atrial Fibrillation

  2023cites this paper
• 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2023cites this paper
• Factors associated with atrial fibrillation in Japanese patients with type 2 diabetes mellitus: a cross-sectional study

  2022cites this paper
• Pharmacokinetic determinants for the right dose of antiarrhythmic drugs

  2022cites this paper
• Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence

  2022cites this paper
• Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics

  2022cites this paper
• Brugada Syndrome.

  2022cites this paper
• A (-)-Carvona Modula a Sinalização de Cálcio Intracelular com Ação Antiarrítmica em Corações de Ratos

  2022cites this paper
• Drug Interactions Affecting Antiarrhythmic Drug Use

  2022cites this paper
• Cardiotoxicity drug screening based on whole-panel intracellular recording.

  2022cites this paper
• Clinical electrophysiology of the aging heart

  2022cites this paper
• The Future of Antiarrhythmic Drug Therapy: Will Drugs Be Entirely Replaced by Procedures?

  2022cites this paper
• Doing the Right Things

  2022cites this paper
• Atrial fibrillation and flutter – the state of the art. Part 2

  2021cites this paper
• Ventricular Arrhythmias

  2021cites this paper
• Antiarrhythmic drugs—safety and efficacy during pregnancy

  2021cites this paper
• 1,3‐Diazepine: A privileged scaffold in medicinal chemistry

  2021cites this paper
• Classification of the mechanisms by which cardiotoxic plant poisons exert their effects

  2021influential citation
• Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

  2021influential citation
• Amiodarone: A Comprehensive Guide for Clinicians

  2020cites this paper
• Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms

  2020cites this paper
• Overdrive pacing of spiral waves in a model of human ventricular tissue

  2020cites this paper
• Frontal plane QRS‐T angle in the monitoring of intravenous amiodarone infusion for pharmacological cardioversion of acute atrial fibrillation

  2020cites this paper
• Quantitative Approach to Fragmented QRS in Arrhythmogenic Cardiomyopathy: From Disease towards Asymptomatic Carriers of Pathogenic Variants

  2020cites this paper
• Mechanisms of action of currently used antiseizure drugs.

  2020cites this paper
• Atrioventricular block in patients undergoing treatment with bradycardic drugs. Predictors of pacemaker requirement.

  2020cites this paper
• Estimation of cardiac electrical activity by invasive and non-invasive mapping techniques

  2019cites this paper
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

  2019cites this paper
• ARRHYTHMIA'S: TYPES, PATHOPHYSIOLOGY AND THERAPY: A REVIEW

  2019cites this paper
• Investigation of antiarrhythmic and proarrhythmic mechanisms in modified systems with molecular biological methods

  2019cites this paper
• Lidocaine for chemical cardioversion of orthodromic atrioventricular reciprocating tachycardia in dogs

  2019cites this paper
• Management of monomorphic ventricular tachycardia electrical storm in structural heart disease

  2019cites this paper
• Cochrane Database of Systematic Reviews External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis (Protocol)

  2019cites this paper
• Inhibitory effects of class I antiarrhythmic agents on Na+ and Ca2+ currents of human iPS cell-derived cardiomyocytes

  2019cites this paper
• Ultrastructural Changes in Cardiac Muscles after Long Term Administration of Amiodarone and Possible Protective Effect of Moringa oleifera Leaf Extract and Mesenchymal Bone Marrow Stem Cell on Adult Male Albino Rats

  2019cites this paper
• The effects of nicotine and cigarette smoking on cardiac electrophysiology.

  2019cites this paper
• Pharmacological Cardioversion of Acute Atrial Fibrillation

  2019cites this paper
• Cardiac sodium channel antagonism - Translation of preclinical in vitro assays to clinical QRS prolongation.

  2018cites this paper
• Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society

  2018cites this paper
• German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management

  2018cites this paper
• Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy

  2018cites this paper
• University of Birmingham German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper

  2018cites this paper
• Outcomes and safety of new techniques for pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation: A study based on randomised trials and registries

  2018cites this paper
• New insights on atrial fibrillation mechanisms through the analysisof structural and electrical features

  2018cites this paper
• Reflections on the early invasive clinical cardiac electrophysiology era through fifty manuscripts: 1967–1992

  2018cites this paper
• University of Southern Denmark Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity An Italian population-based cohort study

  2018influential citation
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2018cites this paper
• Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study

  2018influential citation
• EFFECT OF AMIODARONE IN PREVENTION OF ATRIAL FIBRILLATION IMMEDIATELY AFTER RELEASE OF AORTIC CROSS-CLAMP

  2018cites this paper
• Effects of new antiarrhythmic agent SS-68 on excitation conduction, electrical activity in Purkinje fibers and pulmonary veins: Assessment of safety and side effects risk.

  2017cites this paper
• Cardiac computational modeling of ventricular tachycardia and cardiac resynchronization therapy: a clinical perspective.

  2017cites this paper
• Feasibility of selection of antiarrhythmic drug treatment on the basis of arrhythmogenic mechanism — Relevance of electrical restitution, wavebreak and rotors

  2017cites this paper
• Hopes and disappointments with antiarrhythmic drugs.

  2017cites this paper
• Role of abnormal repolarization in the mechanism of cardiac arrhythmia

  2017cites this paper
• The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis

  2017cites this paper
• Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias.

  2017cites this paper
• 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• Atrial Fibrillation : treatment, associated conditions and quantification of symptoms

  2017cites this paper
• Cardiac heterogeneity and drug‐provoked arrhythmias

  2017cites this paper
• Cytokine Effects on Mechano-Induced Electrical Activity in Atrial Myocardium

  2017cites this paper
• Inhibitory effects of local anesthetics on the proteasome and their biological actions

  2017cites this paper
• Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis

  2017cites this paper
• Modeling Human Atrial Patho-Electrophysiology from Ion Channels to ECG - Substrates, Pharmacology, Vulnerability, and P-Waves

  2016cites this paper
• The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation

  2016cites this paper
• Propafenone shows class Ic and class II antiarrhythmic effects.

  2016cites this paper
• [The Development of Pulmonary Damage When Receiving Amiodarone].

  2016cites this paper
• The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.

  2016cites this paper
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

  2015cites this paper
• Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist.

  2015cites this paper
• In Vitro Early Safety Pharmacology Screening: Perspectives Related to Cardiovascular Safety.

  2015cites this paper
• Importance of Lipophilicity and Polar Surface Area of Compounds on the Transport Activity of Intestinal H+/tertiary Amine Antiporter

  2015cites this paper
• Effects of interleukin-2 on bioelectric activity of rat atrial myocardium under normal conditions and during gradual stretching.

  2015cites this paper
• Perchlorate: water and infant formulae contamination in France and risk assessment in infants

  2015cites this paper
• Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine

  2015cites this paper
• Revisión Interactions between antiarrhythmic drugs and food

  2015cites this paper
• Antiarrhythmic drugs in pregnancy

  2015cites this paper
• The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada

  2015influential citation
• DETERMINATION OF MEXILETINE IN PHARMACEUTICAL PREPARATIONS BY LINEAR SWEEP VOLTAMMETRY

  2015cites this paper
• A multi-scale computational investigation of cardiac electrophysiology and arrhythmias in acute ischaemia

  2014cites this paper
• Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.

  2014cites this paper
• Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era.

  2014cites this paper
• Acquired Electrophysiological Remodeling and Cardiac Arrhythmias

  2014cites this paper
• Atrial fibrillation: antiarrhythmic therapy.

  2014cites this paper
• Class IV antiarrhythmic agents: new compounds using an old strategy.

  2014cites this paper